Skip to main content
OpenTrials
Completed

NCT Number: NCT02701751

Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study)

The primary purpose of this study is to examine the effects of chronic exercise training and an acute session of exercise on key risk factors associated with Metabolic Syndrome (e.g., glucose tolerance, blood lipid profile, and blood pressure) and alterations in subcutaneous adipose tissue structure and metabolic function in overweight adults.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan

Ann Arbor, Michigan, 48109, United States

About this study

Subjects will be asked to complete the Substrate Metabolism Laboratory General Screening Questionnaire and American Heart Association Health/Fitness Questionnaire to determine if they are eligible to complete the preliminary testing procedures. If eligible, subjects will be asked to visit the Substrate Metabolism Laboratory to participate in the preliminary testing procedures (listed below) before participating in the experimental trial.

PRELIMINARY TESTING PROCEDURES:

  • Blood pressure, height and weight measurements
  • Body Composition Assessment (~20 min)
  • Exercise Fitness Test (~10 min)
  • Resting Metabolic Rate (RMR) measurement (~30 min)
  • 3 hour Oral Glucose Tolerance Test (OGTT)

EXPERIMENTAL TRIAL:

The evening before the experimental trial, subjects will eat a standardized dinner meal and snack. The meal and snack must be eaten at specific times as indicated by the research staff. After eating the snack, subjects will need to fast (no food or beverages - besides water) overnight.

Participants who exercise regularly will be instructed to exercise exactly 3 days before the experimental trial, and then abstain from their exercise training program until after the study is complete.

In the morning, subjects will return to the Substrate Metabolism Laboratory. The research team will collect a blood sample from the subject's hand or forearm and a small sample of fat tissue in the subject's abdomen with a needle. Next, subjects will exercise on a treadmill at a moderate intensity for about 1 hour. Immediately after exercising the research team will collect a second blood sample. Subjects will remain in the laboratory for 1 hour after exercising, and then the research team will collect another blood and fat tissue sample. Upon completion of the experimental trial, subjects will be provided a snack before leaving the laboratory.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: 18-40
  • Body Mass Index: 25-35 kg/m2
  • Regular exercisers: (≥4 days/wk of aerobic exercise; 30-60min/session at moderate and vigorous intensities)
  • Non-exercisers: no regularly planned exercise/physical activity
  • Women must have regularly occurring menses and must be premenopausal

Exclusion criteria

  • Blood pressure > 140/90 mm Hg
  • Pregnant or lactating
  • Evidence/history of cardiovascular or metabolic disease
  • Medications known to affect lipid or glucose metabolism

Treatment and study plan

Exercise Session

Other

A blood sample and fat biopsy will be obtained before and after the 60 minute moderate exercise session. There is no drug or device intervention in this study.

Primary outcomes

  1. PPARg mRNA expression

    Time frame: change from baseline at 1 hour post exercise

    The study team will quantify the abundance of key adipogenic markers in adipose tissue biopsy samples

  2. Cytokine abundance in adipose tissue

    Time frame: change from baseline at 1 hour post exercise

    The study team will measure cytokine proteins in adipose tissue

Secondary outcomes

  1. Total Cholesterol

    Time frame: change from baseline at 1 hour post exercise

    Plasma concentrations of total- cholesterol will be measured.

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Registry information

Acronym: ATX

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Mar 8, 2016
Registry last updated
Mar 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.